1. Home
  2. UNB vs CGEN Comparison

UNB vs CGEN Comparison

Compare UNB & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNB
  • CGEN
  • Stock Information
  • Founded
  • UNB 1891
  • CGEN 1993
  • Country
  • UNB United States
  • CGEN Israel
  • Employees
  • UNB N/A
  • CGEN N/A
  • Industry
  • UNB Major Banks
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • UNB Finance
  • CGEN Health Care
  • Exchange
  • UNB Nasdaq
  • CGEN Nasdaq
  • Market Cap
  • UNB 135.8M
  • CGEN 126.2M
  • IPO Year
  • UNB 1998
  • CGEN 2000
  • Fundamental
  • Price
  • UNB $31.40
  • CGEN $1.45
  • Analyst Decision
  • UNB
  • CGEN Strong Buy
  • Analyst Count
  • UNB 0
  • CGEN 2
  • Target Price
  • UNB N/A
  • CGEN $4.00
  • AVG Volume (30 Days)
  • UNB 8.0K
  • CGEN 284.5K
  • Earning Date
  • UNB 10-16-2024
  • CGEN 11-12-2024
  • Dividend Yield
  • UNB 4.62%
  • CGEN N/A
  • EPS Growth
  • UNB N/A
  • CGEN N/A
  • EPS
  • UNB 1.93
  • CGEN 0.02
  • Revenue
  • UNB $46,385,000.00
  • CGEN $59,852,000.00
  • Revenue This Year
  • UNB N/A
  • CGEN $18.69
  • Revenue Next Year
  • UNB N/A
  • CGEN N/A
  • P/E Ratio
  • UNB $16.14
  • CGEN $80.38
  • Revenue Growth
  • UNB N/A
  • CGEN 698.03
  • 52 Week Low
  • UNB $21.00
  • CGEN $0.62
  • 52 Week High
  • UNB $32.00
  • CGEN $3.03
  • Technical
  • Relative Strength Index (RSI)
  • UNB 70.86
  • CGEN 33.42
  • Support Level
  • UNB $29.98
  • CGEN $1.35
  • Resistance Level
  • UNB $31.22
  • CGEN $1.49
  • Average True Range (ATR)
  • UNB 0.86
  • CGEN 0.10
  • MACD
  • UNB 0.07
  • CGEN -0.02
  • Stochastic Oscillator
  • UNB 99.07
  • CGEN 15.90

About UNB Union Bankshares Inc.

Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The company provides retail banking services to individuals and commercial banking services to small and medium-sized corporations, partnerships, and sole proprietorships, as well as nonprofit organizations, local municipalities, and school districts within its market area. In addition, it also offers fiduciary and asset management services through its Asset Management Group. Geographically, all the business activity is functioned through the United States.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: